Treatment of Type 1 Brugada ECG Pattern with Arrhythmic Syncope
Clinical Scenario
This protocol addresses the management of patients presenting with a type 1 Brugada ECG pattern who have experienced arrhythmic syncope — a high-risk combination that requires prompt, structured assessment and intervention planning.
Key Consideration
In patients with a type 1 Brugada pattern and a history of arrhythmic syncope, device therapy warrants consideration as part of the risk-stratification and management pathway.
Treatment Approach
The full protocol outlines specific pharmacological options — including an antiarrhythmic agent — for patients in whom device-based management may not be straightforward. The complete decision pathway, eligibility criteria, and sequencing are available in the full regimen.
References
DOI: 10.1093/eurheartj/ehac262
ICD implantation should be considered in patients with type 1 Brugada pattern and an arrhythmic syncope.
Quinidine should be considered in patients with BrS who qualify for an ICD but have a contraindication, decline, or have recurrent ICD shocks.
View source ↗